1335-P: Serum Granulin Concentrations Are Elevated in Subjects with Impaired Fasting Glucose, Impaired Glucose Tolerance, and Newly Diagnosed Diabetes
Introduction and Objective: Although plasma Hemoglobin A1c (HbA1c) levels and the oral glucose tolerance test (OGTT) are conventional diagnostics for prediabetes, OGTT may be inconvenient for patients due to the need for multiple blood samples. In addition, individuals with impaired fasting glucose...
Saved in:
Published in | Diabetes (New York, N.Y.) Vol. 74; no. Supplement_1; p. 1 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
New York
American Diabetes Association
20.06.2025
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Introduction and Objective: Although plasma Hemoglobin A1c (HbA1c) levels and the oral glucose tolerance test (OGTT) are conventional diagnostics for prediabetes, OGTT may be inconvenient for patients due to the need for multiple blood samples. In addition, individuals with impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) may have a decline in β-cell function independent of HbA1c levels. Therefore, a biomarker for screening prediabetes is important. Granulin is associated with obesity and insulin resistance. However, the serum granulin concentrations in prediabetes and diabetes are still unknown. Thus, the aim of the present study was to investigate the relationship among granulin, IFG, IGT, and newly diagnosed diabetes (NDD).
Methods: A total of 180 age- and sex-matched participants with NGT (n=47), IFG (n=45), IGT (n=48), and NDD (n=40) was recruited for this cross-sectional study. Serum granulin levels were measured by ELISA. Linear regression analysis was used to evaluate the relationship among granulin, IFG, IGT, and NDD.
Results: Serum granulin concentrations were higher in IFG, IGT and NDD groups than those of NGT groups (249.3 ± 62.7, 247.1± 56.7, 232.1 ± 50.6 and 189.7±42.4 ng/ml). In multiple linear regression analysis, IFG (p<0.001), IGT (p<0.001) and NDD (p< 0.01) were the positively associated factors of serum granulin concentrations after adjusting for age, sex, body mass index, blood pressure, lipid profile, creatinine and alanine aminotransferase.
Conclusion: Elevated serum granulin concentrations had a potential to be a novel biomarker for the screening of prediabetes. |
---|---|
AbstractList | Introduction and Objective: Although plasma Hemoglobin A1c (HbA1c) levels and the oral glucose tolerance test (OGTT) are conventional diagnostics for prediabetes, OGTT may be inconvenient for patients due to the need for multiple blood samples. In addition, individuals with impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) may have a decline in β-cell function independent of HbA1c levels. Therefore, a biomarker for screening prediabetes is important. Granulin is associated with obesity and insulin resistance. However, the serum granulin concentrations in prediabetes and diabetes are still unknown. Thus, the aim of the present study was to investigate the relationship among granulin, IFG, IGT, and newly diagnosed diabetes (NDD).
Methods: A total of 180 age- and sex-matched participants with NGT (n=47), IFG (n=45), IGT (n=48), and NDD (n=40) was recruited for this cross-sectional study. Serum granulin levels were measured by ELISA. Linear regression analysis was used to evaluate the relationship among granulin, IFG, IGT, and NDD.
Results: Serum granulin concentrations were higher in IFG, IGT and NDD groups than those of NGT groups (249.3 ± 62.7, 247.1± 56.7, 232.1 ± 50.6 and 189.7±42.4 ng/ml). In multiple linear regression analysis, IFG (p<0.001), IGT (p<0.001) and NDD (p< 0.01) were the positively associated factors of serum granulin concentrations after adjusting for age, sex, body mass index, blood pressure, lipid profile, creatinine and alanine aminotransferase.
Conclusion: Elevated serum granulin concentrations had a potential to be a novel biomarker for the screening of prediabetes. Introduction and Objective: Although plasma Hemoglobin A1c (HbA1c) levels and the oral glucose tolerance test (OGTT) are conventional diagnostics for prediabetes, OGTT may be inconvenient for patients due to the need for multiple blood samples. In addition, individuals with impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) may have a decline in β-cell function independent of HbA1c levels. Therefore, a biomarker for screening prediabetes is important. Granulin is associated with obesity and insulin resistance. However, the serum granulin concentrations in prediabetes and diabetes are still unknown. Thus, the aim of the present study was to investigate the relationship among granulin, IFG, IGT, and newly diagnosed diabetes (NDD). Methods: A total of 180 age- and sex-matched participants with NGT (n=47), IFG (n=45), IGT (n=48), and NDD (n=40) was recruited for this cross-sectional study. Serum granulin levels were measured by ELISA. Linear regression analysis was used to evaluate the relationship among granulin, IFG, IGT, and NDD. Results: Serum granulin concentrations were higher in IFG, IGT and NDD groups than those of NGT groups (249.3 ± 62.7, 247.1± 56.7, 232.1 ± 50.6 and 189.7±42.4 ng/ml). In multiple linear regression analysis, IFG (p<0.001), IGT (p<0.001) and NDD (p< 0.01) were the positively associated factors of serum granulin concentrations after adjusting for age, sex, body mass index, blood pressure, lipid profile, creatinine and alanine aminotransferase. Conclusion: Elevated serum granulin concentrations had a potential to be a novel biomarker for the screening of prediabetes. |
Author | HSU, YUNG-HAN CHON CHAN, KA HSUAN CHOU, YU WU, HUNG-TSUNG OU, HORNG-YIH |
Author_xml | – sequence: 1 givenname: YU surname: HSUAN CHOU fullname: HSUAN CHOU, YU – sequence: 2 givenname: YUNG-HAN surname: HSU fullname: HSU, YUNG-HAN – sequence: 3 givenname: KA surname: CHON CHAN fullname: CHON CHAN, KA – sequence: 4 givenname: HUNG-TSUNG surname: WU fullname: WU, HUNG-TSUNG – sequence: 5 givenname: HORNG-YIH surname: OU fullname: OU, HORNG-YIH |
BookMark | eNpFkFFLwzAUhYMouE2f_AMBH7WaNE3T-TbmNgdDB9uDbyFNbmdHl86kdeyP-HtN2UDuw72c73APnD66tLUFhO4oeYoZE88mj3lEGePR8gL16JANIxaLz0vUI4TGERVDcY363m8JIWmYHvo9uV_wCly7wzOnbFuVFo9rq8E2TjVlbT0eOcCTCn5UAwYHvGrzLejG40PZfOH5bq9KF8hU-aa0GzyrWl17ePwnZwWv6wpChg5MWYPf4VAd8WupNjZQ0105NOBv0FWhKg-35z1A6-lkPX6LFh-z-Xi0iHSaZJEBxbQ2lBcGxBBSzkWRkIyLmENm0iCZVKckyZUgOiuAc1rohPNckSxhwrABuj-93bv6uwXfyG3dOhsSJYuZSIRIsiy4Hk4u7WrvHRRy78qdckdJiex6l13vsmtSLtkf3m54aA |
ContentType | Journal Article |
Copyright | Copyright American Diabetes Association 2025 |
Copyright_xml | – notice: Copyright American Diabetes Association 2025 |
DBID | AAYXX CITATION K9. NAPCQ |
DOI | 10.2337/db25-1335-P |
DatabaseName | CrossRef ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium |
DatabaseTitle | CrossRef ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium |
DatabaseTitleList | CrossRef ProQuest Health & Medical Complete (Alumni) |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1939-327X |
ExternalDocumentID | 10_2337_db25_1335_P |
GroupedDBID | --- .55 .XZ 08P 0R~ 18M 29F 2WC 354 4.4 5GY 5RE 5RS 6PF 8R4 8R5 AAFWJ AAQQT AAWTL AAYEP AAYXX ABOCM ACGFO ACGOD ACPRK ADBBV AEGXH AENEX AERZD AHMBA AIAGR AIZAD ALIPV ALMA_UNASSIGNED_HOLDINGS BAWUL BES BTFSW CITATION CS3 DIK DU5 E3Z EBS EDB EMOBN EX3 F5P FRP GX1 H13 HZ~ IAO IEA IHR INH INR IOF IPO K2M KQ8 L7B M5~ O9- OHH OK1 OVD P2P PCD Q2X RHI RPM SJN SV3 TDI TEORI TR2 VVN WH7 WOQ WOW X7M YFH YHG YOC ZY1 ~KM K9. NAPCQ |
ID | FETCH-LOGICAL-c648-dea3ccd15fde79e6557f4085725e8d679ed6c604ba70c8fe551fc455ba08437d3 |
ISSN | 0012-1797 |
IngestDate | Sat Aug 23 12:59:08 EDT 2025 Thu Jul 03 08:34:13 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | Supplement_1 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c648-dea3ccd15fde79e6557f4085725e8d679ed6c604ba70c8fe551fc455ba08437d3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 |
PQID | 3237477488 |
PQPubID | 34443 |
ParticipantIDs | proquest_journals_3237477488 crossref_primary_10_2337_db25_1335_P |
PublicationCentury | 2000 |
PublicationDate | 2025-06-20 |
PublicationDateYYYYMMDD | 2025-06-20 |
PublicationDate_xml | – month: 06 year: 2025 text: 2025-06-20 day: 20 |
PublicationDecade | 2020 |
PublicationPlace | New York |
PublicationPlace_xml | – name: New York |
PublicationTitle | Diabetes (New York, N.Y.) |
PublicationYear | 2025 |
Publisher | American Diabetes Association |
Publisher_xml | – name: American Diabetes Association |
SSID | ssj0006060 |
Score | 2.4803913 |
Snippet | Introduction and Objective: Although plasma Hemoglobin A1c (HbA1c) levels and the oral glucose tolerance test (OGTT) are conventional diagnostics for... |
SourceID | proquest crossref |
SourceType | Aggregation Database Index Database |
StartPage | 1 |
SubjectTerms | Alanine transaminase Beta cells Biomarkers Blood pressure Body mass index Creatinine Diabetes Diabetes mellitus Fasting Glucose Glucose tolerance Granulin Hemoglobin Insulin resistance Laboratory testing Regression analysis |
Title | 1335-P: Serum Granulin Concentrations Are Elevated in Subjects with Impaired Fasting Glucose, Impaired Glucose Tolerance, and Newly Diagnosed Diabetes |
URI | https://www.proquest.com/docview/3237477488 |
Volume | 74 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKkBAviKsYDOSHvWWBNL4k5a1q16WMTZUoYm9R7DhcVFq0NEjwQ_gj_EGOb0k6TQh4idrjxLJ8vpyL8x0boUOe0qpQbBgmlBW6JCcKhSxFSFhEpKSK01J_0T0759k7-vqCXQwGv3qspWYrXsgf19aV_I9WQQZ61VWy_6DZtlMQwG_QL1xBw3D9Kx1D5sfChU7q4ZVvvgQn4HgMs3yiixHXbkfcOhhfquB4pb4VOryEZrAWnw2Lw6zCzsEifNI09FlRGxL0iaWxG_Ph25wsWG5WSp_FoTztE6zk6jtYTsPYgxsdxabuR73T3gLv1aN_eksRk4-bxriEJsjqpoMt_LHi9Ycw68S6MMISQgJ4shW_Nzdn-uZl3TjH7NY1Yqb5V3HUIdF_sGqHeBWvzqIPY73FqnXayhrxERmFJE4u-lY-oT0zPbzOecTEbD9QChiL1V_nIz0vIBu_zRfTWf5mfn56A92MITfRx2ZM56et-4eM0NY9uYHZolDd-cte17th0G4UYEKb5V10x-UkeGwBdg8N1Po-unXmWBcP0E_b2StsUIY9yvAuyuB5hT3KMDR7lGGNMuyRhB3KsEPUUdfiJLjF2BEGhGGDMNwiDHtVPUTL2fFykoXuPI9QcpqGpSrg9S-HrCpVMlKcsaTS--slMVNpyUFUcskjKookkmmlIJavJGVMFFFKSVKSR2hvvVmrxwhXhUilULwSglAhhwUjsipKpUTFpYj5Pjr0s5t_tbu25JDtaiXkWgm5nrd8sY8O_Mzn7rWucxITSLETcGxP_tz8FN3ucHuA9raXjXoGEepWPDeI-A0sjZRS |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=1335-P%3A+Serum+Granulin+Concentrations+Are+Elevated+in+Subjects+with+Impaired+Fasting+Glucose%2C+Impaired+Glucose+Tolerance%2C+and+Newly+Diagnosed+Diabetes&rft.jtitle=Diabetes+%28New+York%2C+N.Y.%29&rft.au=Chou%2C+Yu+Hsuan&rft.au=Hsu%2C+Yung-Han&rft.au=Chan%2C+Ka+Chon&rft.au=Wu%2C+Hung-Tsung&rft.date=2025-06-20&rft.pub=American+Diabetes+Association&rft.issn=0012-1797&rft.eissn=1939-327X&rft.volume=74&rft.spage=1&rft_id=info:doi/10.2337%2Fdb25-1335-P&rft.externalDBID=HAS_PDF_LINK |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0012-1797&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0012-1797&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0012-1797&client=summon |